Seroatlas · Human Serome Atlas

BTD

Biotinidase

Also known as: BTD_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P43251
Gene
BTD
Ensembl
ENSG00000169814
Chromosome
3
Canonical length
543 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins
Secretome location
Secreted to blood

OverviewNCBI Gene

The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013]

Canonical amino-acid sequenceUniProt

543 residues, UniProt reviewed canonical sequence.

>P43251|BTD
     1  MAHAHIQGGR RAKSRFVVCI MSGARSKLAL FLCGCYVVAL GAHTGEESVA DHHEAEYYVA
    61  AVYEHPSILS LNPLALISRQ EALELMNQNL DIYEQQVMTA AQKDVQIIVF PEDGIHGFNF
   121  TRTSIYPFLD FMPSPQVVRW NPCLEPHRFN DTEVLQRLSC MAIRGDMFLV ANLGTKEPCH
   181  SSDPRCPKDG RYQFNTNVVF SNNGTLVDRY RKHNLYFEAA FDVPLKVDLI TFDTPFAGRF
   241  GIFTCFDILF FDPAIRVLRD YKVKHVVYPT AWMNQLPLLA AIEIQKAFAV AFGINVLAAN
   301  VHHPVLGMTG SGIHTPLESF WYHDMENPKS HLIIAQVAKN PVGLIGAENA TGETDPSHSK
   361  FLKILSGDPY CEKDAQEVHC DEATKWNVNA PPTFHSEMMY DNFTLVPVWG KEGYLHVCSN
   421  GLCCYLLYER PTLSKELYAL GVFDGLHTVH GTYYIQVCAL VRCGGLGFDT CGQEITEATG
   481  IFEFHLWGNF STSYIFPLFL TSGMTLEVPD QLGWENDHYF LRKSRLSSGL VTAALYGRLY
   541  ERD

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against BTD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
94 nTPM

Expression across tissuesHPA

Tissue

  • liver: 94 nTPM
  • epididymis: 60 nTPM
  • duodenum: 47 nTPM
  • pancreas: 44 nTPM
  • kidney: 35 nTPM
  • retina: 32 nTPM

Single-cell type

  • plasma cells: 558 nCPM
  • rod photoreceptor cells: 415 nCPM
  • epicardial cells: 359 nCPM
  • adipocytes: 336 nCPM
  • mast cells: 306 nCPM
  • thymocytes: 267 nCPM

Immune cell

  • basophil: 79 nTPM
  • eosinophil: 49 nTPM
  • T-reg: 31 nTPM
  • plasmacytoid DC: 26 nTPM
  • memory CD4 T-cell: 25 nTPM
  • gdT-cell: 24 nTPM

Brain region

  • cerebellum: 51 nTPM
  • white matter: 51 nTPM
  • medulla oblongata: 38 nTPM
  • basal ganglia: 38 nTPM
  • pons: 36 nTPM
  • hippocampal formation: 36 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about BTD.

Disease | AllUniProt

Conditions BTD is implicated in, by any mechanism.

Disease | GeneticClinVar

253 pathogenic / likely-pathogenic of 773 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.3
gnomAD pLI
0
gnomAD missense Z
-0.53
DepMap mean gene effect
0.23
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

  • biotinidase activity

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads BTD as an antibody target. Whether an autoantibody or antibody against BTD could matter depends on whether native BTD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

BTD is annotated as secreted, so native BTD circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label BTD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/BTD. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...